Tourmaline Bio Inc.

NASDAQ: TRML · Real-Time Price · USD
22.50
0.11 (0.49%)
At close: Aug 15, 2025, 3:59 PM
22.57
0.33%
After-hours: Aug 15, 2025, 04:04 PM EDT

Tourmaline Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-73.21M -42.12M -19.7M -47.83M
Depreciation & Amortization
39K 33K 6K 623K
Stock-Based Compensation
6.59M 5.77M 195K n/a
Other Working Capital
-5.59M -124K 709K 992K
Other Non-Cash Items
-7.53M 8.41M 12.14M 4.91M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-3.15M -168K 902K 2.31M
Operating Cash Flow
-77.26M -28.08M -6.46M -39.99M
Capital Expenditures
-9K -56K -5.07M -2.44M
Cash Acquisitions
n/a n/a -5M n/a
Purchase of Investments
-366.14M -16.6M n/a -275.88M
Sales Maturities Of Investments
171.84M 20.5M n/a 181.93M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-194.31M 3.84M -5.07M -96.39M
Debt Repayment
n/a n/a -150K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-4K -5.57M n/a -277K
Financial Cash Flow
161.35M 156.72M 19.85M 137.4M
Net Cash Flow
-110.22M 132.48M 8.32M 1.02M
Free Cash Flow
-77.27M -28.14M -11.53M -42.42M